CN105158129B - A kind of erythrocyte sedimentation rate (ESR) standard items and preparation method thereof - Google Patents
A kind of erythrocyte sedimentation rate (ESR) standard items and preparation method thereof Download PDFInfo
- Publication number
- CN105158129B CN105158129B CN201510530401.2A CN201510530401A CN105158129B CN 105158129 B CN105158129 B CN 105158129B CN 201510530401 A CN201510530401 A CN 201510530401A CN 105158129 B CN105158129 B CN 105158129B
- Authority
- CN
- China
- Prior art keywords
- red blood
- solution
- erythrocyte sedimentation
- liquid
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
一种红细胞沉降率标准品及其制备方法,包括放置在魏氏血沉管内的仿人类红细胞、保护剂(A液)和保存剂(B液),制备方法如下;Step1,取正在屠宰的经检验检疫合格的家畜新鲜血液按6∶1EDTA抗凝,离心沉淀5分钟后移去上清液;Step2,将离心沉淀之后的底层细胞用A液洗涤,然后再离心沉淀,保留下层红细胞;Step3,将保留的下层红细胞加20倍的B液充分混匀1小时,放置24小时后移去上清液;Step4,然后将收集制备好的混合物按1∶1的比例混匀于A液中制成仿人血红细胞颗粒,通过流式细胞分析仪或血球细胞分析仪,计算其准确细胞数;Step5,将1∶1比例混合物准确计数的仿人血红细胞颗粒与枸橼酸钠按不同的比例浓度注入魏氏血沉管内刻度处,室温静置1小时,然后封口储存。
A standard product of erythrocyte sedimentation rate and a preparation method thereof, including imitation human erythrocytes, a protective agent (liquid A) and a preservative (liquid B) placed in a Widman's erythrocyte sedimentation tube, the preparation method is as follows; Step1, take the tested The fresh blood of domestic animals qualified for quarantine is anticoagulated with 6:1 EDTA, and the supernatant is removed after centrifugation for 5 minutes; Step2, the bottom cells after centrifugation are washed with solution A, and then centrifuged again, and the bottom red blood cells are retained; Step3, the Add 20 times of B solution to the reserved red blood cells and mix thoroughly for 1 hour, and remove the supernatant after standing for 24 hours; Step4, then mix the collected and prepared mixture in A solution at a ratio of 1:1 to make a mock Human red blood cell granules, through the flow cytometer or hematology analyzer, calculate the exact cell number; Step5, inject the human red blood cell granules and sodium citrate in different proportions and concentrations in a 1:1 ratio mixture At the scale inside the Weisser's ESR tube, let it stand at room temperature for 1 hour, and then seal it for storage.
Description
技术领域technical field
本发明涉及医学领域,具体涉及一种红细胞沉降率标准品及其制备方法。The invention relates to the medical field, in particular to an erythrocyte sedimentation rate standard product and a preparation method thereof.
背景技术Background technique
红细胞沉降率,简称血沉,指在规定条件下,离体抗凝全血中的红细胞自然下沉的速率。红细胞沉降标准品是测定红细胞沉降分析仪、操作技术、测定环境溯源性定量分析的计量物质,作为红细胞沉降率分析的室间室外进行质量控制的评价与确保临床检测结果准确性、精密性唯一依据,还能依据用户需求进行高中低定值。目前只有国际上一些先进的国家才有此类产品出现,制备成本高的同时而且标准品只有一个值Erythrocyte sedimentation rate, referred to as erythrocyte sedimentation rate, refers to the natural sinking rate of red blood cells in anticoagulated whole blood in vitro under specified conditions. The erythrocyte sedimentation standard is the metering substance for the determination of the erythrocyte sedimentation analyzer, operating technology, and quantitative analysis of the traceability of the environment. It is the only basis for the evaluation of the quality control of the room and the outside of the erythrocyte sedimentation rate analysis and to ensure the accuracy and precision of clinical test results. , but also according to user needs for high, medium and low value. At present, only some advanced countries in the world have such products. The preparation cost is high and the standard product has only one value.
发明内容Contents of the invention
为解决上述技术问题,本发明的目的在于提供了一种,以解决现有等缺陷。In order to solve the above technical problems, the object of the present invention is to provide a method to solve the existing defects.
为实现上述目的,本发明之一种红细胞沉降率标准品,其特征在于:所述的红细胞沉降率标准品包括放置在魏氏血沉管内的仿人类红细胞、细胞活性保护剂(A液)和细胞活性保存剂(B液);所述的细胞活性保护液(A液)的组成配比为,葡萄糖15-25g/L、硼酸2-6g/L、硼酸纳1-2g/L、腺嘌呤3-5g/L、氟化纳1-2g/L;所述的细胞活性保存液(B液)的组成配比为,磷酸氢二钠36g/L、碳酸二氢钠31g/L、戊二醛25%25mg/L、丙二醇3g/L、小牛血清0.9g/L。In order to achieve the above object, one kind of erythrocyte sedimentation rate standard product of the present invention is characterized in that: described erythrocyte sedimentation rate standard product comprises imitation human erythrocyte, cell activity protective agent (A liquid) and cell Active preservative (B liquid); the composition ratio of described cell activity protection liquid (A liquid) is, glucose 15-25g/L, boric acid 2-6g/L, sodium borate 1-2g/L, adenine 3 -5g/L, sodium fluoride 1-2g/L; The composition ratio of described cell viability preservation solution (B liquid) is, disodium hydrogen phosphate 36g/L, sodium dihydrogen carbonate 31g/L, glutaraldehyde 25% 25mg/L, propylene glycol 3g/L, calf serum 0.9g/L.
该红细胞沉降率标准品的制备方法为:The preparation method of this erythrocyte sedimentation rate standard product is:
Step1,取新鲜的屠宰的经检验检疫合格的家畜新鲜血液按体积6∶1EDTA抗凝,离心沉淀5分钟后移去上清液;Step1, take the fresh slaughtered livestock fresh blood that has passed the inspection and quarantine and anticoagulate by volume 6:1 EDTA, centrifuge for 5 minutes and then remove the supernatant;
Step2,将离心沉淀之后的底层细胞用细胞活性保护剂(A液)洗涤,然后将底层细胞再离心沉淀,反复三次,保留下层红细胞;Step2, wash the bottom cells after centrifugation with a cell activity protection agent (solution A), then centrifuge the bottom cells again, repeat three times, and keep the bottom red blood cells;
Step3,将保留的下层红细胞加20倍的细胞活性保存剂(B液)充分混匀1小时,放置24小时后移去上清液;Step3, add 20 times the cell viability preservative (solution B) to the reserved lower red blood cells and mix well for 1 hour, and remove the supernatant after standing for 24 hours;
Step4,然后将收集制备好的红细胞和细胞活性保存剂(B液)下层混合物按1∶1的比例混匀于细胞活性保护剂(A液)中制成仿人血红细胞颗粒,通过流式细胞分析仪或血球细胞分析仪,计算其准确细胞数;Step4, then mix the collected and prepared red blood cells and the lower layer mixture of cell viability preserving agent (liquid B) in the ratio of 1:1 in the cell viability protecting agent (liquid A) to make human red blood cell granules, and pass flow cytometry Analyzer or hematology analyzer to calculate the exact number of cells;
Step5,将Step4产生的准确计数的仿人血红细胞颗粒与枸橼酸钠按不同的比例浓度注入魏氏血沉管内刻度处,室温静置1小时,然后封口储存。Step5, the accurately counted human red blood cell granules and sodium citrate produced in Step4 were injected into the scale of the Weisserman's erythrocyte sedimentation tube according to different proportions, left at room temperature for 1 hour, and then sealed and stored.
本发明与现有技术相比,其有益效果是:本发明提出的一种红细胞沉降率标准品利用家禽血液中的红细胞制备成仿人类红细胞,并利用细胞活性保护剂(A液),保存剂(B液),模拟人体血液中的渗透压,对仿人血红细胞进行长期的养护、保存。本发明采用检验检疫过的家禽血液,来源经济、绿色环保、无生物安全性危害,完全替代了人血红细胞,稳定性可控,可按临床需求制备成不同数值的红细胞沉降率标准品。Compared with the prior art, the present invention has the beneficial effects that: a kind of erythrocyte sedimentation rate standard product proposed by the present invention utilizes red blood cells in poultry blood to prepare imitation human red blood cells, and utilizes cell activity protective agent (A liquid), preservative (Liquid B), which simulates the osmotic pressure in human blood, and performs long-term maintenance and preservation of human red blood cells. The invention adopts the poultry blood that has been inspected and quarantined, has an economical source, is green and environmentally friendly, and has no biological safety hazards, completely replaces human red blood cells, has controllable stability, and can be prepared into standard products of erythrocyte sedimentation rate with different values according to clinical needs.
附图说明Description of drawings
图1是本发明的红细胞沉降率标准品位于魏氏法血沉管内的示意图;Fig. 1 is the schematic diagram that the erythrocyte sedimentation rate standard product of the present invention is located in the Wei's method erythrocyte sedimentation tube;
附图序号及名称:1、液面,2、红细胞层。The serial numbers and titles of the attached drawings: 1. liquid level, 2. erythrocyte layer.
具体实施方式Detailed ways
为详细说明本发明之技术内容、构造特征、所达成目的及功效,以下兹例举实施例并配合附图详予说明。In order to describe the technical content, structural features, goals and effects of the present invention in detail, the following examples are given to describe the embodiments in conjunction with the accompanying drawings.
实施例1Example 1
请参阅图1所示,本发明提供一种红细胞沉降率标准品及其制备方法,首先利用葡萄糖15g/L、硼酸6g/L、硼酸纳2g/L、腺嘌呤3g/L、氟化纳1g/L配置成细胞活性保护液(A液),然后利用磷酸氢二钠36g/L、碳酸二氢钠31g/L、戊二醛25%25mg/L、丙二醇3g/L、小牛血清0.9g/L配置成细胞活性保存液(B液);然后取正在屠宰的经检验检疫合格的家畜新鲜血液按6∶1EDTA抗凝,离心沉淀5分钟后移去上清液,底层细胞以保护剂洗涤,离心沉淀,反复三次,保留下层红细胞,加20倍的保存剂充分混匀1小时,放置24小时后移去上清液,收集制备好的混合物按1∶1的比例混匀于保护剂(A液)中制成仿人血红细胞;最后将1∶1比例混合物准确计数的仿人血红细胞颗粒,按以下比例浓度注入魏氏血沉管内刻度处,在室温静置1小时,读取血沉管红细胞的下降层与上层透明液体的高度,按下表配比注入1、2、3、4、5血沉管内上下封口,即得到5种规格的标准品。Please refer to shown in Fig. 1, the present invention provides a kind of erythrocyte sedimentation rate standard product and preparation method thereof, at first utilize glucose 15g/L, boric acid 6g/L, sodium borate 2g/L, adenine 3g/L, sodium fluoride 1g /L is configured into a cell activity protection solution (liquid A), and then use disodium hydrogen phosphate 36g/L, sodium bicarbonate 31g/L, glutaraldehyde 25% 25mg/L, propylene glycol 3g/L, calf serum 0.9g /L to prepare cell activity preservation solution (B solution); then take the fresh blood of slaughtered livestock that has passed the inspection and quarantine and anticoagulate with 6:1 EDTA, centrifuge for 5 minutes, remove the supernatant, and wash the bottom cells with a protective agent , centrifugal precipitation, repeated three times, retain the red blood cells in the lower layer, add 20 times the preservative and mix well for 1 hour, after standing for 24 hours, remove the supernatant, collect the prepared mixture and mix it in the protective agent in a ratio of 1:1 ( Prepare humanoid red blood cells in liquid A); finally, inject the simulated human red blood cell particles accurately counted in the 1:1 ratio mixture into the scale of the Weisserman's ESR tube at the following concentration, let it stand at room temperature for 1 hour, and read the ESR tube The height of the descending layer of erythrocytes and the upper layer of transparent liquid is injected into 1, 2, 3, 4, and 5 erythrocyte sedimentation tubes according to the ratio in the table below and sealed up and down to obtain 5 kinds of standard products.
实施例2Example 2
首先利用葡萄糖25g/L、硼酸5g/L、硼酸纳1g/L、腺嘌呤5g/L、氟化纳2g/L配置成细胞活性保护液(A液)然后利用磷酸氢二钠36g/L、碳酸二氢钠31g/L、戊二醛25%25mg/L、丙二醇3g/L、小牛血清0.9g/L配置成细胞活性保存液(B液);然后取正在屠宰的经检验检疫合格的家畜新鲜血液按6∶1EDTA抗凝,离心沉淀5分钟后移去上清液,底层细胞以保护剂洗涤,离心沉淀,反复三次,保留下层红细胞,加20倍的保存剂充分混匀1小时,放置24小时后移去上清液,收集制备好的混合物按1∶1的比例混匀于保护剂(A液)中制成仿人血红细胞;最后将1∶1比例混合物准确计数的仿人血红细胞颗粒,按以下比例浓度注入魏氏血沉管内刻度处,在室温静置1小时,读取血沉管红细胞的下降层与上层透明液体的高度,按下表配比注入1、2、3、4、5血沉管内上下封口,即得到5种规格的标准品。First, use glucose 25g/L, boric acid 5g/L, sodium borate 1g/L, adenine 5g/L, and sodium fluoride 2g/L to prepare a cell activity protection solution (A solution), then use disodium hydrogen phosphate 36g/L, Sodium bicarbonate 31g/L, glutaraldehyde 25% 25mg/L, propylene glycol 3g/L, and calf serum 0.9g/L were prepared into a cell viability preservation solution (B liquid); Anticoagulate the fresh blood of domestic animals with 6:1 EDTA, centrifuge for 5 minutes, remove the supernatant, wash the bottom cells with a protective agent, and centrifuge for three times, keep the lower red blood cells, add 20 times the preservative and mix well for 1 hour. After standing for 24 hours, remove the supernatant, collect the prepared mixture and mix it in the protective agent (solution A) at a ratio of 1:1 to make humanoid red blood cells; Red blood cell granules are injected into the scale of Wei's erythrocyte sedimentation tube according to the following concentration ratio, and stand at room temperature for 1 hour, read the height of the descending layer of erythrocytes in the erythrocyte sedimentation tube and the upper layer of transparent liquid, and inject 1, 2, 3, 4. Seal up and down the inside of the ESR tube to obtain 5 kinds of standard products.
综上所述,仅为本发明之较佳实施例,不以此限定本发明的保护范围,凡依本发明专利范围及说明书内容所作的等效变化与修饰,皆为本发明专利涵盖的范围之内。In summary, it is only a preferred embodiment of the present invention, and does not limit the protection scope of the present invention. All equivalent changes and modifications made according to the scope of the patent of the present invention and the content of the specification are all covered by the patent of the present invention. within.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510530401.2A CN105158129B (en) | 2015-08-26 | 2015-08-26 | A kind of erythrocyte sedimentation rate (ESR) standard items and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510530401.2A CN105158129B (en) | 2015-08-26 | 2015-08-26 | A kind of erythrocyte sedimentation rate (ESR) standard items and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105158129A CN105158129A (en) | 2015-12-16 |
CN105158129B true CN105158129B (en) | 2018-04-17 |
Family
ID=54799065
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510530401.2A Active CN105158129B (en) | 2015-08-26 | 2015-08-26 | A kind of erythrocyte sedimentation rate (ESR) standard items and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105158129B (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1310797A (en) * | 1998-06-30 | 2001-08-29 | 莱密纳股份有限公司 | Cytological and histological fixative composition and methods of use |
CN1683522A (en) * | 2005-03-04 | 2005-10-19 | 江西特康科技有限公司 | Whole blood quality control substance as cell bio-activity protector and its preparing method |
CN103267715A (en) * | 2013-05-16 | 2013-08-28 | 李滨 | Method and device for automatically detecting sedimentation rate of red blood cells |
US20140295404A1 (en) * | 2013-03-01 | 2014-10-02 | Andrew Simon Goldsborough | Sample fixation and stabilisation |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6310732A (en) * | 1986-03-07 | 1988-01-18 | Takeda Chem Ind Ltd | Composition for preserving blood |
-
2015
- 2015-08-26 CN CN201510530401.2A patent/CN105158129B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1310797A (en) * | 1998-06-30 | 2001-08-29 | 莱密纳股份有限公司 | Cytological and histological fixative composition and methods of use |
CN1683522A (en) * | 2005-03-04 | 2005-10-19 | 江西特康科技有限公司 | Whole blood quality control substance as cell bio-activity protector and its preparing method |
US20140295404A1 (en) * | 2013-03-01 | 2014-10-02 | Andrew Simon Goldsborough | Sample fixation and stabilisation |
CN103267715A (en) * | 2013-05-16 | 2013-08-28 | 李滨 | Method and device for automatically detecting sedimentation rate of red blood cells |
Also Published As
Publication number | Publication date |
---|---|
CN105158129A (en) | 2015-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103336110A (en) | Whole blood quality control material and preparation method thereof | |
Pelletier et al. | Platelet function and constituents of platelet rich plasma | |
CN101285841A (en) | Three classifications whole blood quality control substance simulant and method for making same | |
CN102128917A (en) | Clinical biochemical quality control products and preparation process thereof | |
Johnson et al. | Evaluation of the automated collection and extended storage of apheresis platelets in additive solution | |
CN108310014A (en) | A kind of stem cell medicine and preparation method thereof and the application in the drug for preparing prevention injury of lungs | |
CN104705291A (en) | Mononuclear cell frozen stock solution of cord blood, application and preparation method | |
CN109430252A (en) | A kind of stem cell cryopreserving liquid and preparation method thereof | |
JP2008503711A5 (en) | ||
CN102419365B (en) | Preparation method of standard substance for three-differential hematology analyzer | |
CN108148804A (en) | One kind meets clinic bleeding of the umbilicus multipotential stem cell production purification process | |
CN105158129B (en) | A kind of erythrocyte sedimentation rate (ESR) standard items and preparation method thereof | |
Shanwell et al. | Evaluation of platelets prepared by apheresis and stored for 5 days. In vitro and in vivo studies | |
CN107410288A (en) | A kind of storing liquid of human umbilical cord mesenchymal stem cells | |
Hussein et al. | Influence of different storage times and temperatures on blood gas and acid-base balance in ovine venous blood | |
CN100478442C (en) | Whole blood quality control substance as cell bio-activity protector and its preparing method | |
Yang et al. | Effects of irradiation and leukoreduction on down-regulation of CXCL-8 and storage lesion in stored canine whole blood | |
CN102620950B (en) | Platelet preserving agent | |
Oikawa et al. | Feasibility of a closed‐system cell processor (ACP215) for automated preparation of washed platelet concentrates | |
Johnson III et al. | Effect of manually preheparinized syringes on packed cell volume and total solids in blood samples collected from American alligators (Alligator mississippiensis) | |
EP4260703A1 (en) | Anti-lesion storage method and storage system for cells, tissues or organs | |
McDonald et al. | Mechanism of thrombocytopenia induced in mice by anti-platelet serum | |
Armenia et al. | Evaluation of Storage Length to Blood Component Platelet Concentrate Quality in the Blood Bank, Dr. Soetomo General Hospital, Surabaya, Indonesia. | |
CN105875588A (en) | Cell preservation liquid, application thereof, and method for preserving cells | |
MacNutt et al. | Performance of evacuated blood collection tubes at high altitude |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Ding Huanhong Inventor after: Wang Su Inventor after: Zhu Qing Inventor after: Wang Wendong Inventor before: Wang Su Inventor before: Duan Yanli Inventor before: Liu Yong |
|
CB03 | Change of inventor or designer information | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231114 Address after: 519000 room 1301, building 3, scientific research incubation building, phase II, Tsinghua Science Park, 101 University Road, Tangjiawan Town, high tech Zone, Zhuhai, Guangdong Patentee after: Zhuhai Langtai Biotechnology Co.,Ltd. Address before: 430000 floors 1-2, plant 2, economic development zone, Hannan District, Wuhan City, Hubei Province (Wuhan Gaoyuan Biotechnology Development Co., Ltd.) Patentee before: WUHAN DONGFANG HUAKANG TECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20250428 Address after: 702-2, 802, Building 2, No. 90 Chuangzhi Road, Tangjiawan Town, High tech Zone, Zhuhai City, Guangdong Province, 519000 Patentee after: Zhuhai Langyue Biotechnology Co.,Ltd. Country or region after: China Address before: 519000 room 1301, building 3, scientific research incubation building, phase II, Tsinghua Science Park, 101 University Road, Tangjiawan Town, high tech Zone, Zhuhai, Guangdong Patentee before: Zhuhai Langtai Biotechnology Co.,Ltd. Country or region before: China |
|
TR01 | Transfer of patent right |